NCT06716944Enrolling by invitationPhase 1/2
Self-acupuncture for Migraines Feasibility Study
A Feasibility Trial of Self-Acupuncture for Patients With Migraines (SAM)
Source: ClinicalTrials.gov · Last updated 4 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Patients who have had a course of acupuncture at the Royal London Hospital for Integrated Medicine to manage their migraines, and found it effective, will be taught to do self-acupuncture. This is a feasibility study so the main aim is to test the trial design but the researchers will also explore self-acupuncture's effectiveness, acceptability and safety.
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 29 Oct 2024
- Start date
- 13 Sept 2024
- Primary completion date
- Sept 2025
- Lead sponsor
- University of West London
- Diseases
- Migraine
- NCT number
- NCT06716944
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 60
- From 13 Sept 2024 to the primary completion date, Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients currently receiving acupuncture.
- Patients who have previously been taught or have practiced SA.
Other
- Patients unwilling to participate (for instance due to needle phobia).
- Patients with severe clotting dysfunction or who bruise spontaneously.
- Patients unable to complete the questionnaires as judged by the researchers.
- Patients who are assessed as being unable to do SA (such as if they have poor hand function).
Who the study is looking for
- Adult patients aged 18 years old and over.
- Patients with migraines (when topiramate and propranolol are unsuitable).
- Patients who have been referred to the Royal London Hospital for Integrated Medicine (RLHIM) for a course of at least 6 acupuncture sessions to manage their migraines.
- Patients who have completed a course of acupuncture for the management of their migraines at RLHIM and self-declare that they benefitted from it.
- Patients must have completed the course of acupuncture within the last 3 to 24 months.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal London Hospital for Integrated Medicine Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.